OCUGEN, INC. Other Comprehensive Income (Loss), Net of Tax
OCUGEN, INC. (OCGN) reported Other Comprehensive Income (Loss), Net of Tax of $49.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- OCUGEN, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was $49.00K.
- OCUGEN, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was $103.00K.
- OCUGEN, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $46.00K.
- OCUGEN, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was -$28.00K, a 1033.33% decline year-over-year.
- OCUGEN, INC. other comprehensive income (loss), net of tax for fiscal 2025 was $13.00K, a 53.57% decline from fiscal 2024.
- OCUGEN, INC. other comprehensive income (loss), net of tax for fiscal 2024 was $28.00K.
- OCUGEN, INC. other comprehensive income (loss), net of tax for fiscal 2023 was -$6.00K, a 123.08% decline from fiscal 2022.
- OCUGEN, INC. other comprehensive income (loss), net of tax for fiscal 2022 was $26.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $49.00K 10-Q · filed 2026-08-06 | $152.00K derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $103.00K 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $13.00K 10-K · filed 2026-03-04 | |||
| 2025-09-30 | $46.00K 10-Q · filed 2025-11-05 | $18.00K derived: sum of 2 quarters · filed 2026-08-06 | $10.00K derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$28.00K 10-Q · filed 2026-08-06 | -$36.00K derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$8.00K 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $28.00K 10-K · filed 2026-03-04 | |||
| 2024-09-30 | -$5.00K 10-Q · filed 2025-11-05 | -$2.00K derived: sum of 2 quarters · filed 2025-11-05 | $3.00K derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | $3.00K 10-Q · filed 2025-11-05 | $8.00K derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | $5.00K 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | -$6.00K 10-K · filed 2025-03-05 | |||
| 2023-09-30 | $5.00K 10-Q · filed 2024-11-14 | $2.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.00K derived: sum of 3 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$3.00K 10-Q · filed 2024-11-14 | -$4.00K derived: sum of 2 quarters · filed 2024-11-14 | ||
| 2023-03-31 | -$1.00K 10-Q · filed 2024-11-14 | |||
| 2022-12-31 | $26.00K 10-K · filed 2024-04-16 | |||
| 2022-09-30 | $20.00K 10-K · filed 2024-04-16 | $30.00K derived: sum of 2 quarters · filed 2024-04-16 | ||
| 2022-06-30 | $10.00K 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |